email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
796 - 810
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Shanghai Degron Raises $22 Million for Protein Degradation Drugs
$5.00
Available
I-Mab Alters Collaboration with Ferring Pharma for Developing IBD Candidate
$5.00
Available
OnCusp Acquires Global Rights (ex-China) to CDH6 ADC from Multitude Therapeutics
$5.00
Available
Insilico Medicine Completes $60 Million Funding; Will Build Robotic Drug Discovery Lab
$5.00
Available
Henlius Releases Positive Results for PD-1 as First-Line Therapy for SCLC
$5.00
Available
NuProbe Raises $50 Million for Genomics and Molecular Diagnostics
$5.00
Available
Insilico Starts China Trial of AI-Discovered Novel Fibrosis Therapy
$5.00
Available
ProfoundBio Closes $70 Million Series A+ Funding for ADC and Immunotherapy Drugs
$5.00
Available
Sihuan and CTTQ-Akeso Team up to Test AXL Inhibitor and PD-1 in Solid Tumors
$5.00
Available
Vivo Capital Closes First Tranche of China Fund at $600 Million; Aiming for $1.5 Billion
$5.00
Available
SciNeuro Acquires Rights to Lp-PLA2 Inhibitor from GSK for Alzheimer’s
$5.00
Available
Hansoh Publishes Positive Results in ASCO Journal for Third-Gen EGFR-TKI Inhibitor
$5.00
Available
IASO IND for CAR-T to Treat Autoimmune Disease Accepted in China
$5.00
Available
Oncotelic Forms $50 Million Hong Kong JV to Develop Antisense Candidate
$5.00
Available
Legend Bio to Launch CAR-T in Europe for Multiple Myeloma
$5.00
Available